financetom
Business
financetom
/
Business
/
WK Kellogg Shares Fall After Lower Fiscal Q2 Net Sales; Plans Nebraska Plant Closure
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
WK Kellogg Shares Fall After Lower Fiscal Q2 Net Sales; Plans Nebraska Plant Closure
Aug 6, 2024 8:07 AM

10:41 AM EDT, 08/06/2024 (MT Newswires) -- WK Kellogg (KLG) shares fell 1.7% in recent Tuesday trading after the company reported lower net sales for fiscal Q2 and announced a plan to fully close its Omaha, Nebraska plant by the end of 2026.

The company reported fiscal Q2 earnings Tuesday of $0.36 per diluted share, up from $0.32 a year earlier.

Capital IQ estimates weren't available for comparison.

Net sales for the quarter ended June 29 were $672 million, down from $700 million a year earlier.

Two analysts surveyed by Capital IQ expected $671 million.

The company said it now expects 2024 adjusted net sales to be at the lower end of the previously provided guidance range of a 1% drop to a 1% increase.

WK Kellogg also said its board has approved a reorganization plan that will see the company consolidating its manufacturing network by closing its plant in Omaha, Nebraska, with a phased reduction in production starting in late 2025 and full closure by the end of 2026.

The company added that it plans to scale back production at its facility in Memphis, Tennessee, starting in late 2025.

These actions, including estimated headcount additions at plants where the company plans to increase production, would lead to roughly 550 job cuts, WK Kellogg said.

The company said impacted employees have been informed of the reorganization plan, which remains subject to the satisfaction of certain collective bargaining obligations.

The actions under the plan are anticipated to be substantially completed by the end of fiscal year 2026, the company said.

Price: 17.09, Change: -0.30, Percent Change: -1.73

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved